SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

JB Chemicals soars on settling claims raised by Cilag GmbH International and Johnson & Johnson

18 Jul 2013 Evaluate

JB Chemicals & Pharmaceuticals is currently trading at Rs. 78.90, up by 3.80 points or 5.06% from its previous closing of Rs. 75.10 on the BSE.

The scrip opened at Rs. 77.00 and has touched a high and low of Rs. 80.05 and Rs. 76.00 respectively. So far 88790 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 96.40 on 26-Dec-2012 and a 52 week low of Rs. 64.10 on 17-Aug-2012.

Last one week high and low of the scrip stood at Rs. 83.40 and Rs. 73.80 respectively. The current market cap of the company is Rs. 650.16 crore.

The promoters holding in the company stood at 55.87% while Institutions and Non-Institutions held 4.70% and 39.43% respectively.

JB Chemicals & Pharmaceuticals has reached a settlement of all the claims raised by Cilag GmbH International and Johnson & Johnson LLC. Pursuant to this, an amount of Rs 64.50 crore would be released from Escrow Account to Cilag GmbH International and the balance amount of Rs 73.07 cores in the Escrow Account would be released to the company itself.

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

 

JB Chem & Pharma Share Price

1997.35 22.65 (1.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×